Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Marcel Kool

Principal Investigator
--
Phone 088 97 29 000

--

  • Implementation of paediatric precision oncology into clinical practice

    • nov. 2022
    • Karin P.S., Langenberg, et al
    • European Journal of Cancer
  • Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach

    • okt. 2022
    • Irene, Slavc, et al
    • Cancers
  • Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors

    • sep. 2022
    • Lena, Blümel, et al
    • Cell Death and Disease
  • SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors with Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome

    • sep. 2022
    • Martin, Hasselblatt, et al
    • American Journal of Surgical Pathology
  • Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression

    • aug. 2022
    • Andrey, Korshunov, et al
    • Acta Neuropathologica
View all publications